Perimenopausal Hormone Therapy

Perimenopause is the transitional phase leading up to menopause, when hormones are still being produced but in an irregular pattern. Menopause is defined as the point when ovarian hormone production has declined to consistently low levels and menstrual periods have stopped for 12 consecutive months.

Perimenopause most commonly begins in the early to mid-40s, but it can start earlier—often in the mid to late 30s. The timing varies significantly between individuals and is influenced by genetics, overall health, and ovarian function.

Perimenopause can last several years, often between 4 to 8 years, though this varies widely. Some women experience a shorter transition, while others may have symptoms for a longer period before reaching menopause.

Symptoms are driven by fluctuating hormone levels rather than steady decline. Estrogen can rise and fall unpredictably, and progesterone may be intermittently absent, leading to changing symptoms from one week—or even one day—to the next.

Yes. Some women continue to have regular cycles in the early stages. Over time, cycles often become less predictable, with changes in timing, flow, and frequency depending on whether ovulation occurs.

Heavier or prolonged bleeding can occur due to the effects of estrogen on the uterine lining when progesterone is not present to balance it. This is a common pattern during perimenopause.

Diagnosis is primarily based on symptoms and cycle patterns. Hormone testing can be helpful, but results must be interpreted carefully, as levels vary depending on timing within the menstrual cycle.

Yes. Although perimenopause is a natural transition, symptoms can be effectively managed with a personalized approach that may include lifestyle strategies, targeted therapies, and hormone support when appropriate.